NSG 533 – Advanced Pharmacology | Exam 2 Study
Guide | Wilkes University | 2025/2026 Edition | Questions
and 100% verified answers | Graded A+|latest update
One goal of asthma therapy outline by the NHLBI Expert
Panel 3 guidelines is:
a. ability to use albuterol daily to control symptoms.
b. minimize exacerbations to once a month.
c. keep nighttime symptoms at a maximum of twice a
week.
d. require infrequent use of beta 2 agonists (albuterol) for
relief symptoms. - ANSWER-d. require infrequent use of
beta 2 agonists (albuterol) for relief symptoms.
, A stepwise approach to the pharmacologic management
of asthma:
a. begins with determining the severity of asthma and
assessing asthma control.
b. is used when asthma is severe and requires daily
steroids.
c. allows for each provider to determine their personal
approach to the care of asthmatic patients.
d. provides a framework for the management of severe
asthmatics, but is not as helpful when patients have
intermittent asthma. - ANSWER-a. begins with determining
the severity of asthma and assessing asthma control.
Guide | Wilkes University | 2025/2026 Edition | Questions
and 100% verified answers | Graded A+|latest update
One goal of asthma therapy outline by the NHLBI Expert
Panel 3 guidelines is:
a. ability to use albuterol daily to control symptoms.
b. minimize exacerbations to once a month.
c. keep nighttime symptoms at a maximum of twice a
week.
d. require infrequent use of beta 2 agonists (albuterol) for
relief symptoms. - ANSWER-d. require infrequent use of
beta 2 agonists (albuterol) for relief symptoms.
, A stepwise approach to the pharmacologic management
of asthma:
a. begins with determining the severity of asthma and
assessing asthma control.
b. is used when asthma is severe and requires daily
steroids.
c. allows for each provider to determine their personal
approach to the care of asthmatic patients.
d. provides a framework for the management of severe
asthmatics, but is not as helpful when patients have
intermittent asthma. - ANSWER-a. begins with determining
the severity of asthma and assessing asthma control.
